Do analysts rate TLRY or ACB?

Tilray Brands currently has a consensus target price of $11.50, indicating a potential upside of 149.46%. Given Tilray Brands' stronger consensus rating and higher probable upside, equities research analysts plainly believe Tilray Brands is more favorable than Aurora Cannabis. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tilray Brands 1 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.25 Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts rate CGC or TLRY?

Tilray Brands has a consensus target price of $11.50, suggesting a potential upside of 149.46%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts clearly believe Tilray Brands is more favorable than Canopy Growth. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17 Tilray Brands 1 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.25

Does the media prefer CGC or TLRY?

In the previous week, Tilray Brands had 12 more articles in the media than Canopy Growth. MarketBeat recorded 21 mentions for Tilray Brands and 9 mentions for Canopy Growth. Tilray Brands' average media sentiment score of 0.64 beat Canopy Growth's score of 0.12 indicating that Tilray Brands is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Canopy Growth 2 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Tilray Brands 9 Very Positive mention(s) 4 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor TLRY or CRON?

In the previous week, Tilray Brands had 18 more articles in the media than Cronos Group. MarketBeat recorded 21 mentions for Tilray Brands and 3 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.71 beat Tilray Brands' score of 0.64 indicating that Cronos Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tilray Brands 9 Very Positive mention(s) 4 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cronos Group 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer TLRY or OGI?

Tilray Brands presently has a consensus price target of $11.50, suggesting a potential upside of 149.46%. Given Tilray Brands' higher probable upside, equities analysts plainly believe Tilray Brands is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tilray Brands 1 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.25 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Which has better earnings and valuation, SNDL or TLRY?

SNDL has higher earnings, but lower revenue than Tilray Brands. SNDL is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SNDL $677.32M 0.54 -$11.29M -$0.03 N/A Tilray Brands $821.31M 0.65 -$2.19B -$13.65 N/A

Is SNDL or TLRY more profitable?

SNDL has a net margin of -1.19% compared to Tilray Brands' net margin of -156.51%. SNDL's return on equity of -1.02% beat Tilray Brands' return on equity. Company Net Margins Return on Equity Return on Assets SNDL -1.19% -1.02% -0.85% Tilray Brands -156.51% -3.31% -2.42%

Does the media refer more to SNDL or TLRY?

In the previous week, Tilray Brands had 20 more articles in the media than SNDL. MarketBeat recorded 21 mentions for Tilray Brands and 1 mentions for SNDL. Tilray Brands' average media sentiment score of 0.64 beat SNDL's score of 0.00 indicating that Tilray Brands is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SNDL 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Tilray Brands 9 Very Positive mention(s) 4 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Tilray Brands (TLRY) Competitors

$4.61 +0.02 (+0.44%)

Closing price 04:00 PM Eastern

Extended Trading

$4.62 +0.01 (+0.33%)

As of 07:56 PM Eastern

Compare

TLRY vs. ACB, CGC, CRON, OGI, and SNDL

Should you buy Tilray Brands stock or one of its competitors? MarketBeat compares Tilray Brands with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Tilray Brands include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), and SNDL (SNDL). These companies are all part of the "pharmaceutical products" industry.

How does Tilray Brands compare to Aurora Cannabis?

Tilray Brands (NASDAQ:TLRY) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, media sentiment, analyst recommendations, dividends, earnings and profitability.

Tilray Brands has a beta of 1.88, indicating that its share price is 88% more volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.53, indicating that its share price is 47% less volatile than the broader market.

In the previous week, Tilray Brands had 21 more articles in the media than Aurora Cannabis. MarketBeat recorded 21 mentions for Tilray Brands and 0 mentions for Aurora Cannabis. Tilray Brands' average media sentiment score of 0.64 beat Aurora Cannabis' score of 0.00 indicating that Tilray Brands is being referred to more favorably in the media.

Company	Overall Sentiment
Tilray Brands	Positive
Aurora Cannabis	Neutral

Aurora Cannabis has a net margin of -33.57% compared to Tilray Brands' net margin of -156.51%. Aurora Cannabis' return on equity of 0.10% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-156.51%	-3.31%	-2.42%
Aurora Cannabis	-33.57%	0.10%	0.07%

9.4% of Tilray Brands shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 0.8% of Tilray Brands shares are held by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Aurora Cannabis has lower revenue, but higher earnings than Tilray Brands. Aurora Cannabis is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	$821.31M	0.65	-$2.19B	-$13.65	N/A
Aurora Cannabis	$247.82M	0.71	-$88.13M	-$1.56	N/A

Tilray Brands currently has a consensus target price of $11.50, indicating a potential upside of 149.46%. Given Tilray Brands' stronger consensus rating and higher probable upside, equities research analysts plainly believe Tilray Brands is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Tilray Brands beats Aurora Cannabis on 9 of the 16 factors compared between the two stocks.

How does Tilray Brands compare to Canopy Growth?

Canopy Growth (NASDAQ:CGC) and Tilray Brands (NASDAQ:TLRY) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment, risk and earnings.

Tilray Brands has a consensus target price of $11.50, suggesting a potential upside of 149.46%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts clearly believe Tilray Brands is more favorable than Canopy Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Tilray Brands	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25

Canopy Growth has higher earnings, but lower revenue than Tilray Brands. Canopy Growth is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$251.01M	1.52	-$190.29M	-$0.59	N/A
Tilray Brands	$821.31M	0.65	-$2.19B	-$13.65	N/A

Canopy Growth has a net margin of -75.27% compared to Tilray Brands' net margin of -156.51%. Tilray Brands' return on equity of -3.31% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-75.27%	-26.95%	-17.20%
Tilray Brands	-156.51%	-3.31%	-2.42%

Canopy Growth has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 1.88, meaning that its stock price is 88% more volatile than the broader market.

In the previous week, Tilray Brands had 12 more articles in the media than Canopy Growth. MarketBeat recorded 21 mentions for Tilray Brands and 9 mentions for Canopy Growth. Tilray Brands' average media sentiment score of 0.64 beat Canopy Growth's score of 0.12 indicating that Tilray Brands is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Canopy Growth	2 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Tilray Brands	9 Very Positive mention(s)	4 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 9.4% of Tilray Brands shares are held by institutional investors. 0.2% of Canopy Growth shares are held by company insiders. Comparatively, 0.8% of Tilray Brands shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Tilray Brands beats Canopy Growth on 12 of the 16 factors compared between the two stocks.

How does Tilray Brands compare to Cronos Group?

Tilray Brands (NASDAQ:TLRY) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, media sentiment, profitability, valuation and dividends.

Cronos Group has a net margin of -1.14% compared to Tilray Brands' net margin of -156.51%. Cronos Group's return on equity of -1.26% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-156.51%	-3.31%	-2.42%
Cronos Group	-1.14%	-1.26%	-1.20%

Cronos Group has lower revenue, but higher earnings than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	$821.31M	0.65	-$2.19B	-$13.65	N/A
Cronos Group	$146.59M	6.87	-$9.45M	$0.01	270.00

In the previous week, Tilray Brands had 18 more articles in the media than Cronos Group. MarketBeat recorded 21 mentions for Tilray Brands and 3 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.71 beat Tilray Brands' score of 0.64 indicating that Cronos Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tilray Brands	9 Very Positive mention(s)	4 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cronos Group	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Tilray Brands has a beta of 1.88, suggesting that its share price is 88% more volatile than the broader market. Comparatively, Cronos Group has a beta of 0.89, suggesting that its share price is 11% less volatile than the broader market.

9.4% of Tilray Brands shares are owned by institutional investors. Comparatively, 8.7% of Cronos Group shares are owned by institutional investors. 0.8% of Tilray Brands shares are owned by company insiders. Comparatively, 7.8% of Cronos Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Tilray Brands currently has a consensus target price of $11.50, suggesting a potential upside of 149.46%. Cronos Group has a consensus target price of $2.30, suggesting a potential downside of 14.81%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts clearly believe Tilray Brands is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Summary

Cronos Group beats Tilray Brands on 9 of the 16 factors compared between the two stocks.

How does Tilray Brands compare to Organigram Global?

Tilray Brands (NASDAQ:TLRY) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability.

Tilray Brands presently has a consensus price target of $11.50, suggesting a potential upside of 149.46%. Given Tilray Brands' higher probable upside, equities analysts plainly believe Tilray Brands is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Organigram Global has lower revenue, but higher earnings than Tilray Brands. Organigram Global is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	$821.31M	0.65	-$2.19B	-$13.65	N/A
Organigram Global	$185.07M	0.72	-$17.70M	-$0.13	N/A

In the previous week, Tilray Brands had 21 more articles in the media than Organigram Global. MarketBeat recorded 21 mentions for Tilray Brands and 0 mentions for Organigram Global. Tilray Brands' average media sentiment score of 0.64 beat Organigram Global's score of 0.00 indicating that Tilray Brands is being referred to more favorably in the media.

Company	Overall Sentiment
Tilray Brands	Positive
Organigram Global	Neutral

Tilray Brands has a beta of 1.88, meaning that its stock price is 88% more volatile than the broader market. Comparatively, Organigram Global has a beta of 1.43, meaning that its stock price is 43% more volatile than the broader market.

Organigram Global has a net margin of -9.22% compared to Tilray Brands' net margin of -156.51%. Tilray Brands' return on equity of -3.31% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-156.51%	-3.31%	-2.42%
Organigram Global	-9.22%	-13.41%	-9.09%

9.4% of Tilray Brands shares are owned by institutional investors. Comparatively, 34.6% of Organigram Global shares are owned by institutional investors. 0.8% of Tilray Brands shares are owned by company insiders. Comparatively, 0.1% of Organigram Global shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Tilray Brands beats Organigram Global on 10 of the 16 factors compared between the two stocks.

How does Tilray Brands compare to SNDL?

SNDL (NASDAQ:SNDL) and Tilray Brands (NASDAQ:TLRY) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability and media sentiment.

SNDL has higher earnings, but lower revenue than Tilray Brands. SNDL is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SNDL	$677.32M	0.54	-$11.29M	-$0.03	N/A
Tilray Brands	$821.31M	0.65	-$2.19B	-$13.65	N/A

In the previous week, Tilray Brands had 20 more articles in the media than SNDL. MarketBeat recorded 21 mentions for Tilray Brands and 1 mentions for SNDL. Tilray Brands' average media sentiment score of 0.64 beat SNDL's score of 0.00 indicating that Tilray Brands is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SNDL	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Tilray Brands	9 Very Positive mention(s)	4 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

9.4% of Tilray Brands shares are owned by institutional investors. 0.8% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

SNDL currently has a consensus target price of $5.00, suggesting a potential upside of 249.65%. Tilray Brands has a consensus target price of $11.50, suggesting a potential upside of 149.46%. Given SNDL's higher probable upside, equities analysts clearly believe SNDL is more favorable than Tilray Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SNDL	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Tilray Brands	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25

SNDL has a net margin of -1.19% compared to Tilray Brands' net margin of -156.51%. SNDL's return on equity of -1.02% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SNDL	-1.19%	-1.02%	-0.85%
Tilray Brands	-156.51%	-3.31%	-2.42%

SNDL has a beta of 0.91, meaning that its stock price is 9% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 1.88, meaning that its stock price is 88% more volatile than the broader market.

Summary

Tilray Brands beats SNDL on 10 of the 16 factors compared between the two stocks.

Get Tilray Brands News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TLRY vs. The Competition

Export

Metric	Tilray Brands	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$534.96M	$8.15B	$6.45B	$12.39B
Dividend Yield	N/A	2.60%	2.69%	5.83%
P/E Ratio	-0.34	12.30	21.07	22.20
Price / Sales	0.65	6.99	530.36	110.15
Price / Cash	3.18	16.83	44.82	54.51
Price / Book	0.33	3.21	10.79	6.50
Net Income	-$2.19B	$226.25M	$3.56B	$336.88M
7 Day Performance	-5.53%	-3.57%	1.67%	-0.22%
1 Month Performance	-12.85%	-3.72%	0.43%	0.77%
1 Year Performance	27.88%	1.93%	32.84%	31.57%

Tilray Brands Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TLRY Tilray Brands	3.6571 of 5 stars	$4.61 +0.4%	$11.50 +149.5%	+27.5%	$534.96M	$821.31M	N/A	2,842
ACB Aurora Cannabis	0.3321 of 5 stars	$2.84 -1.0%	N/A	-29.7%	$174.22M	$320.59M	N/A	1,028
CGC Canopy Growth	1.4969 of 5 stars	$0.94 -1.7%	N/A	-22.8%	$380.12M	$251.01M	N/A	3,150	Trending News Insider Trade
CRON Cronos Group	1.5352 of 5 stars	$2.67 +0.8%	$2.30 -13.9%	+42.5%	$996.00M	$159.54M	267.27	450	News Coverage
OGI Organigram Global	0.5361 of 5 stars	$0.95 -0.6%	N/A	-25.6%	$134.32M	$274.19M	N/A	1,139

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TLRY) was last updated on 6/23/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tilray Brands (TLRY) Competitors

TLRY vs. ACB, CGC, CRON, OGI, and SNDL

How does Tilray Brands compare to Aurora Cannabis?

Summary

How does Tilray Brands compare to Canopy Growth?

Summary

How does Tilray Brands compare to Cronos Group?

Summary

How does Tilray Brands compare to Organigram Global?

Summary

How does Tilray Brands compare to SNDL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TLRY vs. The Competition

Tilray Brands Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Tilray Brands (TLRY) Competitors

TLRY vs. ACB, CGC, CRON, OGI, and SNDL

How does Tilray Brands compare to Aurora Cannabis?

Which has more risk and volatility, TLRY or ACB?

Does the media favor TLRY or ACB?

Is TLRY or ACB more profitable?

Do insiders & institutionals believe in TLRY or ACB?

Which has stronger earnings & valuation, TLRY or ACB?

Do analysts rate TLRY or ACB?

Summary

How does Tilray Brands compare to Canopy Growth?

Do analysts rate CGC or TLRY?

Which has stronger valuation and earnings, CGC or TLRY?

Is CGC or TLRY more profitable?

Which has more risk & volatility, CGC or TLRY?

Does the media prefer CGC or TLRY?

Do institutionals & insiders have more ownership in CGC or TLRY?

Summary

How does Tilray Brands compare to Cronos Group?

Is TLRY or CRON more profitable?

Which has preferable earnings & valuation, TLRY or CRON?

Does the media favor TLRY or CRON?

Which has more volatility & risk, TLRY or CRON?

Do insiders and institutionals hold more shares of TLRY or CRON?

Do analysts prefer TLRY or CRON?

Summary

How does Tilray Brands compare to Organigram Global?

Do analysts prefer TLRY or OGI?

Which has stronger valuation & earnings, TLRY or OGI?

Does the media refer more to TLRY or OGI?

Which has more risk and volatility, TLRY or OGI?

Is TLRY or OGI more profitable?

Do institutionals & insiders hold more shares of TLRY or OGI?

Summary

How does Tilray Brands compare to SNDL?

Which has better earnings and valuation, SNDL or TLRY?

Does the media refer more to SNDL or TLRY?

Do institutionals and insiders hold more shares of SNDL or TLRY?

Do analysts prefer SNDL or TLRY?

Is SNDL or TLRY more profitable?

Which has more volatility and risk, SNDL or TLRY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TLRY vs. The Competition

Tilray Brands Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools